Symptoms of Infection

ORB Research & Broadcasting · 2026 · $6.99 · Simulation · deal grade B

Measured on 2026-09-21 16:47 UTC, 14 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $323 to $485 per month
• Opportunity: $525 per month at x1.30 dormancy
• Estimated lifetime owners: 2.5k
• 91% positive across 64 reviews · 6.9 reviews/month

Why it's flagged

• Developer active, last post 0 months ago
• Last build shipped 0 months ago
• Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-19; the live figures above take precedence over any numbers in it.

Symptoms of Infection is a medical-horror simulation in early access that combines diagnostic gameplay with psychological mystery.

A compact indie title with unusually high player sentiment (90%+ positive) and authentic medical-procedural appeal that's moving quietly through early access. The community is engaged and explicitly hungry for content expansion, suggesting strong word-of-mouth potential if development accelerates. Most interesting for a publishing or studio-partnership angle: the developer appears to be a solo or micro-team operation with clear creative vision but limited bandwidth. Acquisition would be speculative given the early-stage build and single-title catalog. Most realistic play: publishing.

• Risk: Game is days old in build cycle with no discount history or established sales velocity; sustainability of monthly residuals is untested.
• Risk: Medical-simulation audience is niche; early-access release timing and content pacing will determine whether players churn or convert to full release purchases.
• Risk: Single-person or tiny team: development cadence and long-term commitment are unknown; publisher support may be critical for timely content delivery and community retention.

This case as Markdown · Estimates carry ±30-50% error per title.